-+ 0.00%
-+ 0.00%
-+ 0.00%

VISTAGEN THERAPEUTICS - TOPLINE RESULTS FROM PALISADE-4 PHASE 3 TRIAL EXPECTED IN Q2 2026

Reuters·06/09/2026 12:31:23

Please log in to view news